Seeking Alpha

Cerus (CERS) announces a secondary offering for an undisclosed amount. The company anticipates...

Cerus (CERS) announces a secondary offering for an undisclosed amount. The company anticipates using the net proceeds for clinical development and other R&D and marketing activities related to its Intercept Blood System, plus other general corporate purposes. CERS may also use a portion of the net proceeds from the offering to prepay the remaining outstanding indebtedness under its growth capital loan with Comerica Bank. Cowen is acting as sole book-runner. Shares -0.5% AH.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs